J-Lex

Bennett Tablets 17.5mg

Bennett Tablets 17.5mg, produced by Takeda Pharmaceutical, features Risedronate sodium hydrate, a bisphosphonate medication used to prevent and treat osteoporosis and Paget’s disease. Each tablet contains 17.5mg, and the YJ code is 3999019F2030.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

Contact us about this drug →

More with the same ingredient

More from this manufacturer